Skip to content
‹ Back to IndustriesHealthcare

The Innovators Advancing Virtual Care Delivery across North America

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.   Technology has become the true innovator in healthcare, and with great technical and medical…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

Technology has become the true innovator in healthcare, and with great technical and medical minds, the next generation of medical devices is here. Talking about their company’s innovations, Rob Kaul, CEO, and Dr. Sonny Kohli, Chief Medical Officer, of Cloud DX, joined I Don’t Care. 

Kaul started the company over a decade ago with a focus on technology that was a new way to measure blood measure. Kaul and Dr. Kohli became acquainted over their shared vision. They ended up pursuing the XPRIZE for remote diagnostics and monitoring.

“It’s part of the Connected Health Platform and is FDA cleared and commercially available, helping those with COPD and congestive heart failure” – Robert Kaul

Dr. Kohli said, “The challenge was to create smartphone-based technology that could diagnose conditions and monitor vital signs in the cloud, which you could then apply analytics.”

They ended up winning with VITALITI, a wearable piece that can measure almost every vital sign. It’s currently in trials for FDA approval.

VITALTI, beyond the wearable, has a base station that can measure samples of fluid and diagnose and software that uses AI. “It can ask about symptoms, and we were looking at ways to diagnose pneumonia,” Kaul said.

That led them to a company in Boston that created technology to diagnose respiratory conditions based on coughing, which they licensed.

With the XPRIZE funding, the company began testing the cough technology to diagnose Tuberculosis, specifically in Mozambique, where it’s an epidemic. “It’s a major issue in the country, and detecting is very expensive, so this is a noninvasive way that can be a great screening tool,” Dr. Kohli explained.

The guests then went back to the blood pressure device, which is the Pulsewave. “It measures blood pressure differently,” Kaul noted. It has greater accuracy and delivers more data to identify arrhythmia or even if patients aren’t taking their medication.

“It’s part of the Connected Health Platform and is FDA cleared and commercially available, helping those with COPD and congestive heart failure,” Kaul said.

It’s the next horizon of remote patient monitoring and moving toward data-driven healthcare, which could improve patient outcomes.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

SCI recruits funeral sales as the career AI cannot replace

SCI recruits funeral sales as the career AI cannot replace

SCI's recruiting video positions funeral and cremation sales as a career resistant to automation by emphasizing the human trust required in end-of-life planning. The pitch frames the role as requiring both compassion and sales drive, targets people outside the industry, and leans on demographic demand from an aging population to argue for job stability.

  • 01More than 11,000 Americans turn 65 daily, SCI says demand will grow.
  • 02SCI seeks candidates with dual traits: compassion and empathy alongside sales-oriented drive and tenacity.
  • 03The role requires no prior industry experience; SCI provides training, coaching, and technology to prepare newcomers.

Oct 7, 2026

CURORI Details Readiness Framework for Planned Ten-City Expansion in China

CURORI, a China-based medical-aesthetic coordination platform founded in 2025, has outlined a readiness framework to expand its city coverage from five to ten Chinese destinations by the end of 2027. The expansion will be phased around provider and service readiness rather than destination count alone, with review areas including qualified doctors, licensed institutions, procedure categories, communication processes, and practical factors for international users.

  • 01CURORI plans to expand from five currently served cities (Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou) to ten by December 31, 2027, with Chengdu, Xi'an, Wuhan, and two additional locations under evaluation.
  • 02The company's readiness framework requires operational checks across provider qualifications, licensed institutions, procedure availability, assessment requirements, communication processes, quotation clarity, appointment coordination, and follow-up arrangements before launching in new cities.
  • 03CURORI has a separate objective to help reduce client costs by approximately 10% by the end of 2026 through comparison, clearer quotation information, free initial coordination, and future incentives.

Oct 7, 2026

Some hospices saw daily patient census rise 50% in the 18 to 36 months after rebranding

Some hospices saw daily patient census rise 50% in the 18 to 36 months after rebranding

Some hospice clients saw ADC climb 50% in 18 to 36 months. Expanding beyond hospice is the biggest driver, and the payoff takes years.

  • 01Service diversification beyond hospice care is one of three common rebrand triggers, so the name often trails a business that has already changed.

Oct 6, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512